Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Different LD of Ticagrelor for Antiplatelet Effect in Patients With Non-ST-segment Elevation ACS Undergoing PCI

This study has been completed.
Information provided by (Responsible Party):
General Hospital of Chinese Armed Police Forces Identifier:
First received: October 10, 2013
Last updated: December 17, 2015
Last verified: September 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2015
  Primary Completion Date: October 2015 (Final data collection date for primary outcome measure)